Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant SARS-CoV-2 Spike anticorps

Reactivité: SARS Coronavirus-2 (SARS-CoV-2) ELISA Hôte: Human Monoclonal AM018553 (553-18) unconjugated Recombinant Antibody
N° du produit ABIN6972679
  • Antigène Voir toutes SARS-CoV-2 Spike Anticorps
    SARS-CoV-2 Spike
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    • 85
    • 10
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    SARS Coronavirus-2 (SARS-CoV-2)
    Hôte
    • 32
    • 30
    • 22
    • 2
    • 2
    • 1
    • 1
    Human
    Clonalité
    • 56
    • 19
    • 12
    Monoclonal
    Conjugué
    • 78
    • 5
    • 3
    • 1
    Cet anticorp SARS-CoV-2 Spike est non-conjugé
    Application
    • 65
    • 31
    • 28
    • 10
    • 8
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA
    Attributs du produit
    COVID-19, which is short for coronavirus disease 2019, is the official name of the respiratory disease caused by infection with the novel coronavirus SARS-CoV-2. The virus that causes COVID-19 was named SARS-CoV-2 because it is a coronavirus genetically similar to, yet distinct from, the virus that caused the severe acute respiratory syndrome (SARS) outbreak in 2003. Studying the details of how this virus replicates and causes the disease will allow scientists and physicians to more rapidly develop fast and accurate methods of detection as well as to deploy therapeutic and vaccine strategies. This antibody was derived from COVID-19 patients who have cleared the virus. Patient serum IgG was sequenced and expressed as full-length IgG1 with human immunoglobulin heavy and light chains in mammalian 293 cells. SARS-CoV-2 Spike Antibody (AM3) (Clone AM3 (553-18)) was raised in a Human host. It has been validated for use in ELISA, it has been shown to react with Virus samples.
    Purification
    Protein A Chromatography
    Immunogène
    Derived from COVID-19 patients who have cleared the virus. Their antibodies were screened for reactivity to SARS-CoV-2 and then sequenced and expressed as recombinant antibodies.
    Clone
    AM018553 (553-18)
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product SARS-CoV-2 Spike Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Buffer
    140 mM Hepes, pH 7.5, 70 mM NaCl, 32 mM NaOAc, 0.035 % sodium azide, and 30 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage.
  • Antigène
    SARS-CoV-2 Spike
    Abstract
    SARS-CoV-2 Spike Produits
    Synonymes
    anticorps E2, anticorps E2 glycoprotein precursor, anticorps Surface Glycoprotein, anticorps S
    Classe de substances
    Viral Protein
    Poids moléculaire
    141 kDa (full length S1 protein)
Vous êtes ici:
Support technique